Anticancer agent 158 (compound 7c) demonstrates potent efficacy against various cancer cell lines, with IC50 values of 7.93 µM for HepG-2, 9.28 µM for MDA-MB-231, and 13.28 µM for HCT-116, however, it exhibits reduced potency with an IC50 of 181.89 µM ag
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
